Eastwood Bio Medical Canada Stock Number Of Employees
| EBM Stock | CAD 0.40 0.05 14.29% |
Eastwood Bio Medical Canada fundamentals help investors to digest information that contributes to Eastwood Bio's financial success or failures. It also enables traders to predict the movement of Eastwood Stock. The fundamental analysis module provides a way to measure Eastwood Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eastwood Bio stock.
Eastwood |
Eastwood Bio Medical Canada Company Number Of Employees Analysis
Eastwood Bio's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Eastwood Bio Number Of Employees | 2 |
Most of Eastwood Bio's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eastwood Bio Medical Canada is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, Eastwood Bio Medical Canada is currently employing 2.0 people. This is 99.98% lower than that of the Consumer Staples Distribution & Retail sector and 99.63% lower than that of the Consumer Staples industry. The number of employees for all Canada stocks is 99.99% higher than that of the company.
Eastwood Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Eastwood Bio's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Eastwood Bio could also be used in its relative valuation, which is a method of valuing Eastwood Bio by comparing valuation metrics of similar companies.Eastwood Bio is currently under evaluation in number of employees category among its peers.
Eastwood Fundamentals
| Return On Equity | -7.47 | ||||
| Return On Asset | -0.62 | ||||
| Profit Margin | (0.65) % | ||||
| Operating Margin | (0.63) % | ||||
| Current Valuation | 27.63 M | ||||
| Shares Outstanding | 68.89 M | ||||
| Shares Owned By Insiders | 69.55 % | ||||
| Number Of Shares Shorted | 496 | ||||
| Price To Earning | (11.43) X | ||||
| Price To Book | 2,943 X | ||||
| Price To Sales | 39.25 X | ||||
| Revenue | 702.08 K | ||||
| Gross Profit | 454.39 K | ||||
| EBITDA | (333.01 K) | ||||
| Net Income | (455.87 K) | ||||
| Cash And Equivalents | 708.26 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 79.61 K | ||||
| Current Ratio | 3.42 X | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (15.22 K) | ||||
| Short Ratio | 0.16 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Beta | -0.044 | ||||
| Market Capitalization | 27.55 M | ||||
| Total Asset | 274.29 K | ||||
| Retained Earnings | (5.99 M) | ||||
| Working Capital | (1.53 M) | ||||
| Net Asset | 274.29 K |
About Eastwood Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eastwood Bio Medical Canada's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eastwood Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eastwood Bio Medical Canada based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Eastwood Stock Analysis
When running Eastwood Bio's price analysis, check to measure Eastwood Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio is operating at the current time. Most of Eastwood Bio's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio's price. Additionally, you may evaluate how the addition of Eastwood Bio to your portfolios can decrease your overall portfolio volatility.